Emergency signs need emergency care. Call 911 for severe or worsening abdominal pain, heavy rectal bleeding, repeated vomiting with an inability to keep fluids down, a high fever with a swollen tender abdomen, fainting, or signs of severe dehydration.
Both are chronic immune-mediated inflammatory conditions of the digestive tract, grouped together as inflammatory bowel disease, and they differ mainly in which parts of the tract inflame and how far through the bowel wall that inflammation reaches. Research suggests that inflammatory bowel disease arises from an interaction between genetic susceptibility, the intestinal environment and an immune response that stays switched on far longer than it should 1.
That shared mechanism explains why the two overlap so much on paper. Both can cause diarrhoea, abdominal pain, urgency, fatigue and weight change. Both run in cycles of flare and remission rather than a steady line. Both can involve tissues outside the gut, including joints, skin and eyes 1. Both are long-term conditions that are managed over years rather than resolved in a single episode.
Where they part company is anatomy. Ulcerative colitis is confined to the colon and rectum, and the inflammation sits in the mucosa, the thin inner lining 2. Crohn's disease is not confined anywhere. It can appear in any segment from the mouth to the anus, frequently skipping healthy stretches in between, and it can inflame the entire thickness of the bowel wall 1.
That anatomical split is not a technicality. It shapes which symptoms dominate, which complications become possible, which nutrients are at risk, and which parts of the body a clinician keeps an eye on over the following decades. Two people can describe almost identical days and still have two different conditions underneath, which is why the labels are settled with objective findings rather than symptom descriptions alone.
Ulcerative colitis starts at the rectum and extends upward through the colon in one continuous, unbroken segment, while Crohn's disease can appear in any part of the gastrointestinal tract and typically does so in patches. In ulcerative colitis, how far that continuous inflammation reaches defines the extent of disease, and research suggests that extent ranges from inflammation limited to the rectum, through left-sided involvement, to inflammation of most or all of the colon 2.
That extent matters for practical reasons. Guidelines indicate that establishing how much of the colon is involved, alongside how severe the inflammation is, shapes how ulcerative colitis is assessed and followed over time 3. Someone with inflammation limited to the rectum often has a very different day to day experience from someone whose entire colon is involved, even though both carry the same diagnosis.
Crohn's disease follows no such orderly pattern. The most commonly affected region is the last part of the small intestine and the adjacent right side of the colon, but involvement of the upper gut, the small bowel alone, the colon alone, or the area around the anus all occur 1. Normal-looking tissue frequently sits between inflamed segments, which is where the term skip lesions comes from.
The practical consequence is that a localised examination can miss Crohn's disease entirely. Inflammation in the small intestine sits out of reach of an examination that only looks at the colon, which is one reason imaging of the small bowel often forms part of the workup 4. Ulcerative colitis, by contrast, is always within reach of a colonic examination because it always involves the rectum.
Ulcerative colitis inflames the surface lining, while Crohn's disease can extend through the full thickness of the bowel wall, and that single difference drives most of the complications that separate the two. In ulcerative colitis, the inflamed mucosa becomes friable and ulcerated, which is why visible blood in the stool is such a characteristic feature 2.
In Crohn's disease, inflammation that passes through the muscular layers of the wall can leave behind consequences the surface-only pattern does not produce. Repeated cycles of inflammation and healing can thicken and narrow a segment, producing obstruction-type symptoms such as cramping after meals, bloating and vomiting. Inflammation that tunnels outward can create abnormal connections between the bowel and nearby structures, or collections of infection near the anus 1.
This is also why the two conditions produce different bleeding patterns. Surface ulceration bleeds readily, so bloody diarrhoea dominates in ulcerative colitis. Deeper, patchier inflammation in the small bowel may cause pain, weight loss and fatigue with little visible blood, which is part of why Crohn's disease can be mistaken for a functional gut problem for a long stretch.
Depth also changes what absorption looks like. The colon absorbs water and electrolytes, so widespread colonic inflammation tends to cause frequent, urgent, watery and bloody stools. The small intestine absorbs most nutrients, so inflammation there can quietly produce deficiencies before anything dramatic happens in the bathroom. That is the single most useful mental model for reading the differences between these two conditions.
The clearest way to hold the distinction is a direct comparison of location, pattern, depth and the consequences each produces.
| Feature | Ulcerative colitis | Crohn's disease |
|---|---|---|
| Area involved | Colon and rectum only | Any site from mouth to anus, most often the last part of the small intestine and right colon |
| Pattern | Continuous from the rectum upward | Patchy, with normal tissue between inflamed segments |
| Depth in the bowel wall | Inner lining (mucosa) | Can extend through the full wall thickness |
| Rectum | Essentially always involved | May be spared |
| Typical dominant symptom | Bloody diarrhoea with urgency | Abdominal pain, diarrhoea, weight loss, often without visible blood |
| Area around the anus | Not a feature | Pain, drainage or openings near the anus can occur |
| Wall-related complications | Uncommon, inflammation stays superficial | Narrowing, abnormal connections and localised infection are possible |
| Nutrient absorption | Water and electrolyte handling affected | Nutrient absorption can be affected when the small bowel is involved |
| Smoking relationship | More often seen in people who have never smoked or who stopped | Smoking is unfavourable |
The pattern summarised above follows what current reviews and guidelines describe for each condition 1 2 4. Research suggests that smoking behaves differently across the two conditions, with smoking carrying an unfavourable relationship with Crohn's disease in particular 1.
One caution about tables. These are tendencies, not rules. Plenty of people sit awkwardly across the columns, and the features that look decisive in a summary are far less tidy in a real clinic. The table is a way to understand the logic, not a self-assessment tool.
Symptoms point in a direction but rarely settle the question on their own, because the overlap between the two conditions is substantial. Ulcerative colitis classically presents with bloody diarrhoea, urgency and a persistent sensation of needing to pass stool even when the bowel is empty, and research suggests these are the features that most consistently bring people to care 2.
Crohn's disease tends to announce itself less obviously. Cramping abdominal pain, often in the lower right abdomen, loose stools without visible blood, fatigue, low-grade fever, reduced appetite and unintended weight loss are common opening features 1. When the area around the anus is involved, pain, swelling or drainage can be the first thing noticed, and that pattern points strongly away from ulcerative colitis.
Both conditions can also show up outside the gut before the gut itself becomes loud. Joint pain and swelling, inflammatory skin lesions, eye inflammation and mouth ulcers all occur in inflammatory bowel disease 1. Someone who has had unexplained joint and eye inflammation alongside bowel symptoms has a story worth describing to a clinician in full rather than in pieces across separate appointments.
There is a further complication. Symptom intensity does not reliably track inflammation. People can feel reasonably well with ongoing inflammation present, and others can feel unwell during a period of healed lining because of changed bowel habit, scarring or an overlapping functional gut problem. That mismatch is precisely why objective measures sit alongside symptom reports rather than behind them, and research suggests that assessment of inflammation itself, not just how someone feels, now anchors long-term care 4.
It matters because location and depth change what is monitored, which complications are plausible, which nutrients are at risk, and what a clinician considers appropriate. Guidelines indicate that assessment of disease extent and severity directs how ulcerative colitis is managed and followed 3, and broader guidance sets out separate pathways for the two conditions across diagnosis and long-term care 4.
In practical terms, a person whose inflammation involves the last part of the small intestine faces different nutritional risks from a person whose inflammation is limited to the rectum. A person with full-thickness inflammation needs attention to the possibility of narrowing or tunnelling that a person with surface inflammation does not. Long-term surveillance of the colon is approached differently depending on how much colon is involved and for how long 3.
The distinction also changes the questions worth asking. For small bowel involvement, absorption and micronutrient status become central. For extensive colonic involvement, hydration, blood loss and the sheer frequency of symptoms dominate. Treatment decisions belong to a licensed provider, who weighs the specific pattern alongside history, test results and preference.
None of this means the label is fixed forever. Diagnoses are revisited as more information accumulates, and a picture that looked like one condition at the start is sometimes reclassified later. The purpose of the distinction is not to put a permanent sticker on someone. It is to make the next decision a better one.
C-reactive protein is a blood protein the liver releases when inflammation is present anywhere in the body, so it gives a rough read on inflammatory activity rather than a location. The dedicated C-Reactive Protein guide covers the test, its interpretation and its limits in full. In brief, labs typically regard 0 to 3 mg/L as the standard reference range, while FitScript's optimal range is 0 to 1 mg/L, an optimization target rather than a diagnostic cut-off. Reference ranges vary by lab, age and sex. A raised value suggests inflammation somewhere, not which condition is behind it, and a value inside the range does not rule out limited or superficial inflammation of the bowel lining. It is one input among many, read alongside symptoms and the rest of the workup.
Albumin is the most abundant protein in blood, and a value below the usual range in someone with gut symptoms is a signal worth exploring rather than a diagnosis. Albumin falls for several overlapping reasons. Sustained inflammation shifts the liver toward producing other proteins, protein can be lost through an inflamed bowel lining, and reduced intake or impaired absorption lowers the raw material available.
That combination makes albumin a crude but useful summary of how much strain the system is under. A gradually falling value across repeated tests in someone with known inflammatory bowel disease usually prompts a closer look at both inflammation and nutrition together rather than at either one alone. Research suggests that nutritional status is closely tied to the course of inflammatory bowel disease, which is why nutrition is assessed rather than assumed 5.
The interpretive sequence is worth spelling out. The observation is a low albumin result. What it may reflect is ongoing inflammation, protein loss, inadequate intake, impaired absorption, liver or kidney factors, or simply dilution from fluid status. What it is not is proof of any single condition. The next step is to bring the value to a clinician alongside symptoms, weight trend and the rest of the panel, because the meaning changes entirely depending on that context.
A value inside the standard range does not exclude active inflammation either, particularly in milder or more localised disease. Albumin moves slowly, so it tends to describe sustained strain better than a short flare.
Vitamin B12 is absorbed almost entirely in the last section of the small intestine, so a persistently low B12 in someone with inflammatory bowel disease raises the question of whether that specific segment is inflamed or has been surgically removed. This is one of the few places where a routine blood marker carries genuine anatomical information.
Ulcerative colitis does not involve the small intestine, so it does not interfere with B12 absorption directly. Crohn's disease affecting the last part of the small intestine can. Research suggests that micronutrient deficiencies, including vitamin B12, are common in inflammatory bowel disease and relate to which segments of bowel are involved and to prior surgery 5. A low B12 therefore nudges the picture toward small bowel involvement, without settling it.
Several other explanations exist and need ruling out before anatomy is blamed. Low dietary intake, particularly on plant-based eating patterns, is a frequent cause. Reduced stomach acid production and various absorption problems unrelated to inflammatory bowel disease also lower B12. Some medicines affect B12 status, and a prescriber is the right person to ask about anything currently being taken.
The practical effects of low B12 include fatigue, enlarged red blood cells, mouth soreness and, if sustained, nerve symptoms such as numbness or tingling. Those symptoms can be mistaken for the general fatigue of active inflammation, which is why the value is checked rather than inferred. What happens next, including whether anything is needed, is a decision for a clinician who can see the full picture.
The most informative additions are the ones that describe blood loss, iron status, nutrient reserves and organ involvement, because those are the areas where both conditions leave fingerprints. A full blood count shows whether anaemia is present and what shape the red cells take, which separates iron-type patterns from B12 or folate-type patterns.
Iron studies deserve particular care in inflammatory conditions. Ferritin reflects iron stores but also rises with inflammation, so a value that looks reassuring can sit on top of genuinely depleted iron. Reading ferritin next to an inflammatory marker, transferrin saturation and the full blood count gives a far more honest picture than ferritin alone. Research suggests that iron deficiency is among the most frequent nutritional problems in inflammatory bowel disease 5.
Folate and vitamin D are worth including for the same reason, since research suggests that deficiencies across several micronutrients are common in these conditions and track with disease course 5. Liver enzymes are also informative, because ulcerative colitis is associated with an inflammatory condition of the bile ducts in a minority of people, and a persistent abnormality in those enzymes is a finding a clinician follows up rather than repeats indefinitely 2.
Tracking these together over time is more revealing than any single draw. A membership that tests 150+ biomarkers per year, as FitScript does, with interpretation by Atlas, its AI health advisor, makes those trends easier to see, though a licensed provider decides on any next step.
Confirmation comes from combining the clinical history with laboratory results, imaging and direct examination of the bowel lining with tissue samples, because no single test carries the answer. Guidelines indicate that diagnosis in inflammatory bowel disease rests on this combination rather than on any individual finding 4, and that the same combination establishes extent and severity in ulcerative colitis 3.
Blood work cannot separate the two conditions. Inflammatory markers rise in both, anaemia occurs in both, and both can produce entirely unremarkable blood results during quieter periods. What blood work does well is flag that something inflammatory or nutritional is going on, track change over time, and surface the specific clues, such as B12 status, that hint at which part of the gut is involved.
Sometimes the features genuinely overlap. When inflammation is confined to the colon but the findings do not fit either pattern cleanly, the label inflammatory bowel disease unclassified is used, and it is revisited as more information accumulates. That is an honest description of uncertainty rather than a failure of testing.
Delay is common, particularly in Crohn's disease. Studies suggest that the interval between first symptoms and diagnosis in adults tends to be longer in Crohn's disease than in ulcerative colitis 6. The reasons are not mysterious. Visible blood prompts rapid action, whereas intermittent pain, fatigue and loose stools without blood get attributed to diet, stress or a functional gut problem for months. Keeping a dated record of symptoms, stool changes, weight and fever, and presenting it as one continuous story, is the single most useful thing a person can do to shorten that interval.
Several conditions produce a similar symptom set, which is why confirmation relies on objective findings rather than the symptom story alone. Infectious gastroenteritis is the most common mimic and usually resolves, though a prolonged infectious episode can look convincingly like a first flare.
Irritable bowel syndrome overlaps heavily on symptoms and differs fundamentally on mechanism, since it does not involve inflammation of the bowel lining. It can also coexist with inflammatory bowel disease, which is why symptoms alone are an unreliable guide to whether inflammation is active.
Celiac disease shares both symptoms and some immune features with inflammatory bowel disease, and research suggests the two can occur in the same person more often than coincidence would predict, so testing for one does not remove the reason to consider the other 7. Both can produce diarrhoea, weight loss, fatigue and nutritional deficiencies, and both are lifelong immune conditions of the gut.
Microscopic colitis is another consideration, producing watery diarrhoea with a colon that looks normal to the naked eye and shows inflammation only under a microscope. Some medicines also irritate the gut or alter bowel habit, and a prescriber is the right person to ask about anything currently being taken. Nothing in this list should be self-diagnosed, and a clinician decides which of these possibilities deserves testing.
Plenty of things unrelated to the underlying condition move both symptoms and inflammatory markers, which is why a single result is weaker evidence than a trend. A recent infection, including an ordinary respiratory illness, raises inflammatory markers for a period. Recent injury, dental infection or surgery does the same.
Body composition contributes to baseline inflammatory signal, since adipose tissue produces inflammatory mediators. Sleep loss, heavy unaccustomed exercise in the days before a draw, and smoking all influence the picture. Pregnancy and hormonal contraception shift several laboratory values, and so do some medicines, which is a question for the prescriber rather than for a search engine.
On the symptom side, the usual suspects apply. Changes in fibre intake, caffeine, alcohol, travel, some medicines and periods of high stress all change bowel habit without necessarily changing inflammation. This is exactly the trap that makes self-interpretation unreliable, because a genuine flare and a bad fortnight can feel identical from the inside.
The practical response is consistency. Testing under similar conditions, at a similar time of day, noting any recent illness, and comparing results across several draws rather than agonising over one, produces a far more honest signal. If a result is unexpectedly outside the standard range, repeating it after any acute illness has settled is often more informative than acting on the first value, and that decision belongs with a clinician.
Any persistent change in bowel habit lasting more than a few weeks, and any visible blood in the stool at all, deserves assessment rather than waiting. These symptoms have many causes, most of them not inflammatory bowel disease, but they are not symptoms to sit on.
Red flags that warrant prompt medical attention include blood in the stool, diarrhoea that wakes you at night, unintended weight loss, persistent fever, pain or drainage around the anus, iron deficiency anaemia without an obvious cause, and symptoms that continue after an infection has cleared. A family history of inflammatory bowel disease, celiac disease or bowel cancer makes the case for earlier assessment stronger.
For someone already diagnosed, the moments to make contact are a change in the usual pattern, a flare that does not settle, new symptoms outside the gut such as eye pain or significant joint swelling, and laboratory values that drift in the wrong direction across repeated tests. A value that is outside the standard range is worth discussing with a clinician promptly rather than monitored privately.
The emergency signs named at the top of this page are different in kind and need emergency care, not an appointment next week.
This page is educational and is not medical advice. Bring your results, your symptom record and any questions about next steps to a clinician or licensed provider, who can interpret them against your full history.
The two are considered separate conditions, so a person is not usually given both labels at once. When inflammation is limited to the colon but the findings do not fit either pattern cleanly, clinicians may use the label inflammatory bowel disease unclassified. That label is revisited as more information becomes available over time.
No. Inflammatory markers, blood counts and nutrient levels can all be abnormal in either condition, and both can look unremarkable during quieter periods. Blood work is useful for flagging inflammation, tracking change over time and pointing toward which part of the gut may be involved, but the distinction is settled with imaging and direct examination of the bowel lining with tissue samples.
Not necessarily. C-reactive protein can sit inside the standard range when inflammation is limited in extent or confined to the surface lining. A value inside the range is reassuring in context but does not rule out active bowel inflammation, which is why it is read alongside symptoms and other findings by a clinician.
Vitamin B12 is absorbed in the last part of the small intestine. Crohn's disease can inflame that segment, and surgery to remove it reduces absorption further. Ulcerative colitis does not involve the small intestine, so B12 absorption is generally unaffected, and a low value in that setting usually points to diet or another cause worth investigating.
Neither is inherently more serious. Both range from mild and well controlled to severe and highly disruptive, and the course varies widely between individuals. A clinician assesses severity using symptoms, laboratory results and the extent of inflammation rather than the label alone.
One condition does not convert into the other, but a diagnosis can be revised. As new findings appear, such as inflammation in the small intestine or involvement of the area around the anus, the original label may be reconsidered. This reflects more complete information rather than a change in the underlying condition.
A low albumin value suggests the body is under strain from some combination of sustained inflammation, protein loss through an inflamed bowel lining, reduced intake or impaired absorption. It is a prompt to look more closely, not a diagnosis of anything. Bring the result to a clinician alongside your symptoms, weight trend and the rest of the panel.
Testing frequency depends on how active the condition is, what was found previously and what is being followed, so a clinician sets the interval for each person. Repeating a surprising result after any short-term illness has settled is often more informative than reacting to a single value. A trend across several draws tells a far more reliable story than one snapshot.